Mindset Pharma Stock Price To Sales
Mindset Pharma fundamentals help investors to digest information that contributes to Mindset Pharma's financial success or failures. It also enables traders to predict the movement of Mindset OTC Stock. The fundamental analysis module provides a way to measure Mindset Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mindset Pharma otc stock.
Mindset |
Mindset Pharma OTC Stock Price To Sales Analysis
Mindset Pharma's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Mindset Pharma Price To Sales | 4.83 X |
Most of Mindset Pharma's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mindset Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Mindset Pharma has a Price To Sales of 4.8286 times. This is 77.44% lower than that of the Healthcare sector and 95.09% lower than that of the Biotechnology industry. The price to sales for all United States stocks is 57.72% higher than that of the company.
Mindset Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mindset Pharma's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mindset Pharma could also be used in its relative valuation, which is a method of valuing Mindset Pharma by comparing valuation metrics of similar companies.Mindset Pharma is currently under evaluation in price to sales category among its peers.
Mindset Fundamentals
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 | |||
| Profit Margin | (1.64) % | |||
| Operating Margin | (1.33) % | |||
| Current Valuation | 19.22 M | |||
| Shares Outstanding | 95.25 M | |||
| Shares Owned By Insiders | 9.00 % | |||
| Shares Owned By Institutions | 0.88 % | |||
| Price To Book | 28.87 X | |||
| Price To Sales | 4.83 X | |||
| Revenue | 3.91 M | |||
| Gross Profit | 3.91 M | |||
| EBITDA | (16.53 M) | |||
| Net Income | (16.61 M) | |||
| Cash And Equivalents | 8.71 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 171.79 K | |||
| Debt To Equity | 0.12 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 385.56 K | |||
| Earnings Per Share | (0.19) X | |||
| Target Price | 5.02 | |||
| Beta | -0.28 | |||
| Market Capitalization | 20.95 M | |||
| Total Asset | 9.77 M | |||
| Z Score | 69.3 | |||
| Net Asset | 9.77 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |